<DOC>
	<DOCNO>NCT01508962</DOCNO>
	<brief_summary>The goal PRESS-ALS study early manifestation disease people early ALS area body yet affect .</brief_summary>
	<brief_title>PRE-Symptomatic Studies ALS</brief_title>
	<detailed_description />
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Inclusion Criteria ALS group : Subject male female , age least 18 year . Subject affected ALS ( familial sporadic ) . Subject least one limb symptomatic upper low motor neuron dysfunction . Subject willing able comply study procedure . Subject agree provide sign date informed consent form . Control group : Subject male female , age least 18 year . Subject affected ALS ALSrelated disorder . Subject family history ( i.e. , least 2 biological relative ) ALS ALSrelated disorder . Subject willing able comply study procedure . Subject agree provide sign date informed consent form . Exclusion Criterion â€¢ Any condition situation , PI 's opinion , could confound biomarker data may interfere significantly individual 's participation compliance study protocol , include limited neurological , psychological and/or medical condition ( e.g. , multiple sclerosis , neuropathy , myelopathy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Disease onset</keyword>
	<keyword>Disease progression</keyword>
</DOC>